Invention Grant
- Patent Title: Quil A fraction with low toxicity and use thereof
- Patent Title (中): Quil一种毒性低的药物及其用途
-
Application No.: US10562866Application Date: 2004-07-07
-
Publication No.: US08821881B2Publication Date: 2014-09-02
- Inventor: Bror Morein , Karin Lovgren Bengtsson , Jill Ekstrom , Katarina Ranlund , Kefei Hu
- Applicant: Bror Morein , Karin Lovgren Bengtsson , Jill Ekstrom , Katarina Ranlund , Kefei Hu
- Applicant Address: SE Uppsala
- Assignee: Novavax AB
- Current Assignee: Novavax AB
- Current Assignee Address: SE Uppsala
- Agency: Pearne & Gordon LLP
- Priority: SE0301998 20030707
- International Application: PCT/SE2004/001038 WO 20040707
- International Announcement: WO2005/002620 WO 20050113
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/385 ; A61K45/00

Abstract:
Fraction A of Quil A can be used together with at least one other adjuvant for the preparation of an adjuvant composition, where the included adjuvant components act synergistically to enhance level of immune response and have synergistic immunomodulating activity on the co-administered antigens or immunogens.Other adjuvants can comprise saponins, naturally occurring, synthetic or semisynthetic saponin molecules; e.g. saponins and saponin fractions from Quil A, cell wall skeleton, blockpolymers, TDM, lipopeptides, LPS and LPS-derivatives, Lipid A from different bacterial species and derivatives thereof, e.g., monophosphoryl lipid A. CpG variants, CT and LT or fractions thereof.
Public/Granted literature
- US20060239963A1 Quil a fraction with low toxicity and use thereof Public/Granted day:2006-10-26
Information query